Dual Metabolomic Platforms Identified a Novel Urinary Metabolite Signature for Hepatitis B Virus-Infected Patients with Depression

OBJECTIVE: Depression could make the treatment outcome worse. However, up to now, no objective methods were developed to diagnose depression in hepatitis B virus (HBV)-infected patients. Therefore, the dual metabolomic platforms were used here to identify potential biomarkers for diagnosing HBV-infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jing, Chen, Chang, Hou, Li-juan, Zhou, Chan-juan, Fang, Liang, Chen, Jian-jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244355/
https://www.ncbi.nlm.nih.gov/pubmed/32547129
http://dx.doi.org/10.2147/DMSO.S251034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244355/
https://www.ncbi.nlm.nih.gov/pubmed/32547129
http://dx.doi.org/10.2147/DMSO.S251034

Ejemplares similares